If we’re truly serious about being outcomes oriented in healthcare, we can’t come near accomplishing what we’d like to accomplish without direct intervention with regard to social determinants, explained Clifford Goodman, PhD, senior vice president and director, Center for Comparative Effectiveness Research, The Lewin Group.
This page contains sponsored advertising.
If we’re really truly serious about being outcomes oriented in healthcare, we can’t come near accomplishing what we’d like to accomplish without direct intervention with regard to social determinants, explained Clifford Goodman, PhD, senior vice president and director, Center for Comparative Effectiveness Research, The Lewin Group.
Transcript
Social determinants of health have been gaining a lot of attention-how involved do you think healthcare should be in addressing social determinants?
With regard to social determinants of healthcare and outcomes, in particular, it’s about time we’re realizing how important they are. I’ve seen credible estimates saying that social determinants of healthcare outcomes account for perhaps anywhere from 40% to 60% of differences and outcomes. This is not an inconsequential amount, and if we’re really truly serious about being outcomes oriented in healthcare, we can’t come near accomplishing what we’d like to accomplish without direct intervention with regard to those social determinants.
Also, we’re finding out, and to somewhat our chagrin, that the social determinants are many and they are diverse. We’ve got to deal with housing, education, food insecurity, domestic abuse, and on and on and on; lead in the paint and lead in the water. We’re just going to have a ceiling effect. If we don’t address these social determinants of health, there’s just so much we can accomplish. There’s not enough headroom to accomplish what we need until we address social determinants of health. I would expect that integrated delivery networks and other organizations in healthcare that are responsible for longitudinal management of populations are kind of getting queued into this a lot better than others, but we’ve got a lot of work to do.
How ready to get involved with addressing social determinants of health is the US healthcare system?
Some sectors of our healthcare system are more ready than others to address those needs in social determinants. If you are an integrated delivery network, if you have responsibility to manage a population, you have the incentive and you’ve got the perspective to care about social determinants of health.
However, as we all know, our health care system is set in certain ways to manage what we’ve done for decades. Fee-for-service for what doctors do, what hospitals do, what laboratories do, and what pharmaceuticals do. The system is not set up to be sufficiently integrated to breach those silos across these different systems. How do you hook up a traditional healthcare system to housing insecurity or homeless? How do you hook that up to a poor educational system? How do you hook that up to the water system?
We’re not designed to do this. We don’t get paid, we don’t get incentivized to be as broad as we need to be. So, we have a long way to go. There are, again, integrated delivery networks and other groups that care about managing populations have more to say about this, and I hope greater leverage.
Global Status of HIV/AIDS Pandemic Takes Center Stage in Opening Session
March 10th 2025The Conference for Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about the progress, and lack of progress, has been made in the fight against the HIV pandemic given the current political climate.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Reviving the Classics: The Role of Older Medications in Modern Dermatology
March 9th 2025Older, generic medications, including ones for cyclosporine, nicotinamide, and dapsone, can effectively treat patients with various dermatological conditions while helping to reduce insurance and cost barriers.
Read More
Ruxolitinib Cream Shows Long-Term Safety in AD, Potential for PN Treatment
March 8th 2025Two posters presented at the 2025 American Academy of Dermatology Annual Meeting reaffirmed the impact of ruxolitinib cream (Opzelura; Incyte) in atopic dermatitis (AD), while late-breaking research highlighted its potential efficacy in prurigo nodularis (PN).
Read More
Global Status of HIV/AIDS Pandemic Takes Center Stage in Opening Session
March 10th 2025The Conference for Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about the progress, and lack of progress, has been made in the fight against the HIV pandemic given the current political climate.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Reviving the Classics: The Role of Older Medications in Modern Dermatology
March 9th 2025Older, generic medications, including ones for cyclosporine, nicotinamide, and dapsone, can effectively treat patients with various dermatological conditions while helping to reduce insurance and cost barriers.
Read More
Ruxolitinib Cream Shows Long-Term Safety in AD, Potential for PN Treatment
March 8th 2025Two posters presented at the 2025 American Academy of Dermatology Annual Meeting reaffirmed the impact of ruxolitinib cream (Opzelura; Incyte) in atopic dermatitis (AD), while late-breaking research highlighted its potential efficacy in prurigo nodularis (PN).
Read More
2 Commerce Drive
Cranbury, NJ 08512